Pharmacovigilance Market Summary
Allied Market Research published a research study on the global pharmacovigilance industry, which offers industry dynamics, including growth drivers, challenges, and opportunities. It provides a competitive landscape of the sector and helps stakeholders to derive insights about market trends and investment opportunities in the sector. According to the report, the pharmacovigilance market was valued at $8.2 billion in 2024. It is projected to reach $26.2 billion by 2034, growing at a CAGR of 12.3% from 2025 to 2034.
The comprehensive study utilizes Porter’s five forces analysis to assess industry structure, while covering aspects such as competitive rivalry, the threat of new entrants, and the bargaining power of buyers and suppliers.
Increase in trends of outsourcing services owing to benefits offered by outsourced compliance providers over in-house compliance functions, and increase in adverse drug reactions and drug toxicity, boost growth of the market. Furthermore, growing opportunities in emerging economies create a lucrative opportunity for market growth
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/A49004
Important Questions Answered in the Report
- What are the key factors driving the growth of this industry?
- Which companies are the leading players in the domain?
- Which distribution channel leads the pharmacovigilance market?
- What are the factors that restrain the growth of the sector?
- What is the dominating segment based on product?
Primary Drivers of the Pharmacovigilance Market
The research report provides an in-depth analysis of the key factors that drive the growth of the pharmacovigilance industry. Pharmacovigilance is a scientific field that focuses on detection, understanding, assessment, and prevention of adverse effects of drugs or drug-related issues. It is vital in ensuring the safety and efficacy of the pharmaceutical drug lifecycle, right from clinical trials to post-marketing monitoring. Thus, pharmacovigilance monitors drug performance in the real world, thereby minimizing risks, preventing adverse effects, and enhancing therapeutic outcomes by making informed decisions.
Rise in awareness about drug safety, stringent regulatory mandates, and monitoring of adverse drug reactions across the globe drive the market growth. Rise in drug development with advent of personalized medicine majorly drives the pharmacovigilance market. In addition, pharmacovigilance plays a vital role in ensuring the safety of the patients during all the phases of clinical trials. Rise in adoption of technologies such as AI and ML, help enhance efficiency by reducing human error and automating the process, which is expected to provide lucrative growth opportunities for the pharmacovigilance market.
Leading players in the market are adopting strategies such as product innovation and strategic collaborations to strengthen their market presence and gain a competitive edge in the sector.
Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A49004
Key Benefits for Stakeholders
The AMR report delivers a detailed study of the industry, including a comprehensive competitive landscape. The report highlights emerging trends, key growth drivers, and potential opportunities that empower industry leaders and stakeholders to make informed strategic decisions.
Region wise, North America dominated the pharmacovigilance market owing to a well-0established pharmaceutical industry, strong regulatory framework by regulating agencies such as the U.S. FDA and Health Canada, and high volume of clinical trials in the region. In addition, early adoption of AI, automation, real-time automation and other advanced pharmacovigilance technologies further boost the market growth in the region.
Competitive Landscape
The report profiles top players and analyzes their company strategies, current market share, innovation capabilities, investment portfolios, product innovations, and regional expansion efforts.
Key companies operating in the market include:
- Accenture
- Cognizant
- Oracle Corporation
- Labcorp
- ICON Plc.
- Capgemini
- Clario
- Wipro Limited
- IQVIA
- Parexel
These players have adopted different strategies, such as agreement, acquisition, branding, product launch, and product approval to sustain their foothold in the market
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A49004
The Allied Market Research report on the pharmacovigilance market offers critical insights into this fast-evolving sector. It further highlights key growth drivers, trends, and potential opportunities that empower leading key players in the industry and major stakeholders to make informed strategic decisions. The report serves as a valuable resource for understanding changes in the sector by mitigating risks and supporting long-term business growth by offering in-depth insights in an increasingly competitive environment.
Other Trending Reports in Life Science Domain-
Immune Checkpoint Inhibitors Market From USD 40.1 Billion in 2022 to USD 189.4 Billion by 2032
USD 12.3+ Bn Nerve Repair and Regeneration Market Value Cross by 2030 | Allied Market Research
Brachytherapy Market worth $1.6 billion by 2031 | CAGR of 7.1%
Rabies Vaccine Market to Reach $ 1903.17 million by 2032 | Rising Global Vaccination Programs
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
